ArticleBMC infectious diseases2026
Correlation analysis between the prevalence of hyperuricemia and the triglyceride-glucose index in adult patients with brucellosis.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundBrucellosis and hyperuricemia (HUA) are closely related, and their coexistence and potential interaction may exacerbate disease progression. Triglyceride Glucose (TyG), a simple marker of insulin resistance (IR), is associated with HUA. However, its association with the risk of HUA specifically in patients with brucellosis remains unclear.
methodsThis study employed a retrospective cross-sectional design, incorporating the inpatient records of 649 patients diagnosed with brucellosis at a certain infectious disease hospital in Hohhot City between May 2022 and March 2024. Multivariate logistic regression, generalized additive models with smooth curve fitting, and two-stage linear regression models were employed to assess the relationship between the TyG index and HUA. Subgroup analysis and interaction tests were conducted to assess the stability of the association between the TyG index and HUA in patients with brucellosis. Additionally, the predictive performance of the TyG index for HUA was evaluated using receiver operating characteristic (ROC) curves.
resultsIn this study, 15.4% of brucellosis patients were diagnosed with hyperuricemia. After adjusting for covariates, the risk of HUA increased by 1.90 (1.18-3.06) for each unit increase in the TyG index; the risk of HUA in the fourth quartile of the TyG index was 2.27 times higher than that in the first quartile. A nonlinear relationship was observed between TyG and the risk of HUA in patients with brucellosis, demonstrating an inflection point at 7.827 (P < 0.05). Beyond this threshold, the risk of HUA increased significantly.
conclusionThe TyG index is an independent predictor for the risk of HUA in patients with brucellosis. Assessment of the TyG index may serve as a useful tool for more effectively identifying individuals at increased risk of HUA among patients with brucellosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.